PNEUMONIA TESTING MARKET ANALYSIS
Rising product launch and product approval is expected to drive the market growth. For instance, in November 2018, bioMérieux received 510(k) clearance from the Food and Drug Administration (FDA) for BIOFIRE FILMARRAY Pneumonia Panel which enables diagnosis of lower respiratory tract infections. Similarly, in April 2018, Curetis N.V., received de novo clearance from the U.S. Food and Drug Administration for marketing of Unyvero System and Lower Respiratory Tract Infection (LRT) Application Cartridge an automated molecular diagnostic test in the U.S. The system offers rapid infectious disease testing for detection of Legionella pneumoniae microorganism.
Major players are focused on collaborations and mergers, to enter the pneumonia testing market. For instance, in April 2017, Abbott acquired Alere, which dominated POC testing for pneumonia testing market with its BinaxNOW Streptococcus pneumoniae antigen card for bacterial pneumonia and BinaxNOW RSV Card for viral pneumonia.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
